English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  The apolipoprotein E ɛ4 ( APOE4 ) allele is the strongest genetic risk factor identified for developing Alzheimer’s disease (AD). Among brain lipids, alteration in the ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) homeostasis is implicated in AD pathogenesis.  APOE4  may influence both brain DHA metabolism and cognitive outcomes.    Methods  Using positron emission tomography, regional incorporation coefficients ( k *), rates of DHA incorporation from plasma into the brain using [1- 11 C]-DHA ( J   in ), and regional cerebral blood flow using [ 15 O]-water were measured in 22 middle-aged healthy adults (mean age 35 years, range 19–65 years). Data were partially volume error-corrected for brain atrophy. APOE4 phenotype was determined by protein expression, and unesterified DHA concentrations were quantified in plasma. An exploratory post hoc analysis of the effect of  APOE4  on DHA brain kinetics was performed.    Results  The mean global gray matter DHA incorporation coefficient,  k *, was significantly higher (16%) among  APOE4  carriers ( n  = 9) than among noncarriers ( n  = 13,  p  = 0.046). Higher DHA incorporation coefficients were observed in several brain regions, particularly in the entorhinal subregion, an area affected early in AD pathogenesis. Cerebral blood flow, unesterified plasma DHA, and whole brain DHA incorporation rate ( J   in ) did not differ significantly between the  APOE  groups.    Conclusions  Our findings suggest an increase in the DHA incorporation coefficient in several brain regions in  APOE4  carriers. These findings may contribute to understanding how  APOE4  genotypes affect AD risk.

DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA